Downregulation of MUTYH contributes to cisplatin-resistance of esophageal squamous cell carcinoma cells by promoting Twist-mediated EMT

被引:12
作者
Guo, Yanxia [1 ]
Jia, Yuxiu [1 ]
Wang, Shikang [2 ]
Liu, Ning [3 ]
Gao, Dongfang [1 ]
Zhang, Lu [1 ]
Lin, Zhaomin [1 ]
Wang, Shuling [4 ]
Kong, Feng [1 ]
Peng, Chuanliang [5 ]
Liu, Yongqing [6 ]
机构
[1] Shandong Univ, Hosp 2, Inst Med Sci, Jinan 250033, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp, Dept Emergency Surg, Jinan 250021, Shandong, Peoples R China
[3] Jining Med Univ, Postgrad Dept, Jining 272067, Shandong, Peoples R China
[4] Jinan Cent Hosp, Phys Examinat Ctr, Jinan 250013, Shandong, Peoples R China
[5] Shandong Univ, Hosp 2, Thorac Dept, 247 Beiyuandajie St, Jinan 250033, Shandong, Peoples R China
[6] Shandong Univ, Hosp 2, Dept Clin Pharm, 247 Beiyuandajie St, Jinan 250033, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
MUTYH; cisplatin resistance; epithelial-mesenchymal transition; EMT; Twist; reactive oxygen species; esophageal squamous cell carcinoma; OXIDATIVE STRESS; PATHWAY; REPAIR; POLYMORPHISMS; GENE; ASSOCIATION; MECHANISMS; DAMAGE; OGG1;
D O I
10.3892/or.2019.7347
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acquired resistance to cisplatin (CDDP) in esophageal squamous cell carcinoma (ESCC) remains a major challenge in cancer therapy. Although progress has been made in identifying the mechanisms responsible for resistance to CDDP, the underlying mechanisms of resistance in ESCC are still not entirely understood. In the present study, a CDDP-resistant ESCC cell line EC109/CDDP was established by culturing parental EC109 cells in increasing concentrations of CDDP, and it was demonstrated that MutY homolog (MUTYH), a critical base excision repair gene, was significantly downregulated in the resistant EC109/CDDP cells compared with that noted in the parental cells. Ectopic expression of MUTYH by transient transfection of pcDNA3.1-MUTYH plasmid significantly enhanced the CDDP-mediated inhibitory effect on resistant cell proliferation and induction of apoptosis, while silencing of MUTYH by transiently transfecting MUTYH-targeted siRNA in parental cells led to decreased sensitivity to CDDP as demonstrated by MTT assay, suggesting the crucial involvement of MUTYH in CDDP resistance. Further experiments demonstrated that the CDDP-resistant cells went through epithelial-mesenchymal transition (EMT) driven by its master regulator Twist, and MUTYH overexpression significantly reduced the Twist expression level and reversed the phenotype of EMT as detected by western blot analysis and RT-qPCR assays, suggesting that downregulation of MUTYH contributed to the Twist-mediated EMT. Moreover, it was observed that the effect of MUTYH on Twist was also associated with its degradation in addition to transcription. MUTYH acted as a positive regulator of reactive oxygen species (ROS) that showed a low level in resistant cells via flow cytometry assay, as demonstrated by increased ROS production in response to MUTYH overexpression. Reduced ROS by using N-acetylcysteine led to a decrease in proteasome activity and sequentially inhibited the degradation of Twist. In conclusion, the present data demonstrated that EMT activation mediated by MUTYH downregulation, by both enhancing Twist transcription and blocking its degradation, is one of the mechanisms for acquisition of CDDP resistance in ESCC.C
引用
收藏
页码:2716 / 2727
页数:12
相关论文
共 31 条
  • [1] Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors
    Al-Tassan, N
    Chmiel, NH
    Maynard, J
    Fleming, N
    Livingston, AL
    Williams, GT
    Hodges, AK
    Davies, DR
    David, SS
    Sampson, JR
    Cheadle, JR
    [J]. NATURE GENETICS, 2002, 30 (02) : 227 - 232
  • [2] Neoadjuvant treatment for esophageal squamous cell carcinoma
    Baba, Yoshifumi
    Watanabe, Masayuki
    Yoshida, Naoya
    Baba, Hideo
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 6 (05) : 121 - 128
  • [3] EVALUATION OF CIS-DIAMMINEDICHLOROPLATINUM (II) (CISPLATIN) NEUROTOXICITY IN RATS
    DEKONING, P
    NEIJT, JP
    JENNEKENS, FGI
    GISPEN, WH
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 89 (01) : 81 - 87
  • [4] Regulation of the protein stability of EMT transcription factors
    Diaz, V. M.
    Vinas-Castells, R.
    Garcia de Herreros, A.
    [J]. CELL ADHESION & MIGRATION, 2014, 8 (04) : 418 - 428
  • [5] Association of Base Excision Repair Gene Polymorphisms with the Response to Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Dong, Jie
    Wang, Xu
    Yu, Yu
    Yan, Xu
    Cui, Jiu-Wei
    [J]. CHINESE MEDICAL JOURNAL, 2018, 131 (16) : 1904 - 1908
  • [6] Selectivity of the ubiquitin pathway for oxidatively modified proteins: relevance to protein precipitation diseases
    Dudek, EJ
    Shang, F
    Liu, Q
    Valverde, P
    Hobbs, M
    Taylor, A
    [J]. FASEB JOURNAL, 2005, 19 (10) : 1707 - +
  • [7] Molecular mechanisms of cisplatin resistance
    Galluzzi, L.
    Senovilla, L.
    Vitale, I.
    Michels, J.
    Martins, I.
    Kepp, O.
    Castedo, M.
    Kroemer, G.
    [J]. ONCOGENE, 2012, 31 (15) : 1869 - 1883
  • [8] The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
    Glickman, MH
    Ciechanover, A
    [J]. PHYSIOLOGICAL REVIEWS, 2002, 82 (02) : 373 - 428
  • [9] Protein degradation and protection against misfolded or damaged proteins
    Goldberg, AL
    [J]. NATURE, 2003, 426 (6968) : 895 - 899
  • [10] Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons
    Jiang, Yanlin
    Guo, Chunlu
    Vasko, Michael R.
    Kelley, Mark R.
    [J]. CANCER RESEARCH, 2008, 68 (15) : 6425 - 6434